Skip to main content
Erschienen in: Journal of General Internal Medicine 1/2017

11.10.2016 | Original Research

Patients’ Future Expectations for Diabetes and Hypertension Treatments: “Through the Diet… I Think This is Going to Go Away.”

verfasst von: Paige C. Fairchild, MPH, Aviva G. Nathan, MPH, Michael Quinn, PhD, Elbert S. Huang, MD, MPH, Neda Laiteerapong, MD, MS

Erschienen in: Journal of General Internal Medicine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Diabetes and hypertension are chronic conditions for which over 90 % of patients require medication regimens that must be intensified over time. However, delays in intensification are common, and may be partially due to unrealistic patient expectations.

Objective

To explore whether patient expectations regarding their diabetes and hypertension are congruent with the natural history of these conditions.

Design

Qualitative analysis of semi-structured interviews.

Participants

Sixty adults from an urban academic primary care clinic taking oral medications for both diabetes (duration <10 years) and hypertension (any duration)

Main Measures

(1) Expectations for their a) current diabetes and hypertension medications, b) need for additional medications, c) likelihood of cure (not requiring medications); (2) preferences for receiving information on expected duration of treatments

Key Results

The average patient age was 60 years, and 65 % were women. Nearly half (48 %) of participants expected to discontinue current diabetes medications in 6 years or less, whereas only one-fifth (22 %) expected to take medications for life. For blood pressure medications, one-third (37 %) expected to stop medicines in 6 years or less, and one-third expected to take medicines for life. The vast majority did not expect that they would need additional medications in the future (oral diabetes medications: 85 %; insulin: 87 %; hypertension medications: 93 %). A majority expected that their diabetes (65 %) and hypertension (58 %) would be cured. Most participants believed that intensifying lifestyle changes would allow them to discontinue medications, avoid additional medications, or cure their diabetes and hypertension. Nearly all participants (97 %) wanted to hear information on the expected duration of their diabetes and hypertension treatments from their healthcare provider.

Conclusions

Providers should educate patients on the natural history of diabetes and hypertension in order to manage patient expectations for current and future medications. Future research should assess whether education can increase the adoption of and adherence to medications, without diminishing enthusiasm for lifestyle changes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat American Diabetes Association. Standards of Medical Care in Diabetes - 2015. Diabetes Care. 2015;38(Suppl 1):99. American Diabetes Association. Standards of Medical Care in Diabetes - 2015. Diabetes Care. 2015;38(Suppl 1):99.
2.
Zurück zum Zitat James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507.CrossRefPubMed James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507.CrossRefPubMed
3.
Zurück zum Zitat Gregg EW, Chen H, Wagenknecht LE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308(23):2489–2496.CrossRefPubMedPubMedCentral Gregg EW, Chen H, Wagenknecht LE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308(23):2489–2496.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Karter AJ, Nundy S, Parker MM, Moffet HH, Huang ES. Incidence of remission in adults with type 2 diabetes: the diabetes and aging study. Diabetes Care. 2014;37(12):3188–3195.CrossRefPubMedPubMedCentral Karter AJ, Nundy S, Parker MM, Moffet HH, Huang ES. Incidence of remission in adults with type 2 diabetes: the diabetes and aging study. Diabetes Care. 2014;37(12):3188–3195.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Dannenberg AL, Kannel WB. Remission of hypertension: the “natural” history of blood pressure treatment in the Framingham Study. JAMA. 1987;257(11):1477–1483.CrossRefPubMed Dannenberg AL, Kannel WB. Remission of hypertension: the “natural” history of blood pressure treatment in the Framingham Study. JAMA. 1987;257(11):1477–1483.CrossRefPubMed
6.
Zurück zum Zitat Turner RC, Cull CA, Frighi V, Holman RR, Group UPDSU. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA. 1999;281(21):2005–2012.CrossRefPubMed Turner RC, Cull CA, Frighi V, Holman RR, Group UPDSU. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA. 1999;281(21):2005–2012.CrossRefPubMed
7.
Zurück zum Zitat Stratton I, Manley S, Holman R. Hypertension in diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control. Diabetologia. 1996;39(12):1554–1561.CrossRef Stratton I, Manley S, Holman R. Hypertension in diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control. Diabetologia. 1996;39(12):1554–1561.CrossRef
8.
Zurück zum Zitat Davis J, Chavez B, Juarez DT. Adjustments to diabetes medications in response to increases in hemoglobin a1c: an epidemiologic study. Ann Pharmacother. 2014;48(1):41–47.CrossRefPubMed Davis J, Chavez B, Juarez DT. Adjustments to diabetes medications in response to increases in hemoglobin a1c: an epidemiologic study. Ann Pharmacother. 2014;48(1):41–47.CrossRefPubMed
9.
Zurück zum Zitat Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825–834.CrossRefPubMed Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825–834.CrossRefPubMed
10.
Zurück zum Zitat Hicks PC, Westfall JM, Van Vorst RF, et al. Action or inaction? Decision making in patients with diabetes and elevated blood pressure in primary care. Diabetes Care. 2006;29(12):2580–2585.CrossRefPubMed Hicks PC, Westfall JM, Van Vorst RF, et al. Action or inaction? Decision making in patients with diabetes and elevated blood pressure in primary care. Diabetes Care. 2006;29(12):2580–2585.CrossRefPubMed
11.
Zurück zum Zitat Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med. 2004;21(2):150–155.CrossRefPubMed Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med. 2004;21(2):150–155.CrossRefPubMed
12.
Zurück zum Zitat Ziemer DC, Miller CD, Rhee MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ. 2005;31(4):564–571.CrossRefPubMed Ziemer DC, Miller CD, Rhee MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ. 2005;31(4):564–571.CrossRefPubMed
13.
Zurück zum Zitat Lafata J, Dobie E, Divine G, Ulcickas Yood M, McCarthy B. Sustained hyperglycemia among patients with diabetes: what matters when action is needed? Diabetes Care. 2009;32(8):1447–1452.CrossRefPubMedPubMedCentral Lafata J, Dobie E, Divine G, Ulcickas Yood M, McCarthy B. Sustained hyperglycemia among patients with diabetes: what matters when action is needed? Diabetes Care. 2009;32(8):1447–1452.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Marshall IJ, Wolfe CDA, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345:e3953–e3953.CrossRefPubMedPubMedCentral Marshall IJ, Wolfe CDA, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345:e3953–e3953.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Kronish IM, Leventhal H, Horowitz CR. Understanding minority patients’ beliefs about hypertension to reduce gaps in communication between patients and clinicians. J Clin Hypertens (Greenwich). 2012;14(1):38–44.CrossRef Kronish IM, Leventhal H, Horowitz CR. Understanding minority patients’ beliefs about hypertension to reduce gaps in communication between patients and clinicians. J Clin Hypertens (Greenwich). 2012;14(1):38–44.CrossRef
16.
Zurück zum Zitat Saver BG, Mazor KM, Hargraves JL, Hayes M. Inaccurate risk perceptions and individualized risk estimates by patients with type 2 diabetes. J Am Board Fam Med. 2014;27(4):510–519.CrossRefPubMed Saver BG, Mazor KM, Hargraves JL, Hayes M. Inaccurate risk perceptions and individualized risk estimates by patients with type 2 diabetes. J Am Board Fam Med. 2014;27(4):510–519.CrossRefPubMed
17.
Zurück zum Zitat Strain WD, Cos X, Hirst M, et al. Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014;105(3):302–312.CrossRefPubMed Strain WD, Cos X, Hirst M, et al. Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014;105(3):302–312.CrossRefPubMed
18.
Zurück zum Zitat Ratanawongsa N, Crosson JC, Schillinger D, Karter AJ, Saha CK, Marrero DG. Getting under the skin of clinical inertia in insulin initiation: the Translating Research Into Action for Diabetes (TRIAD) Insulin Starts Project. Diabetes Educ. 2012;38(1):94–100.CrossRefPubMedPubMedCentral Ratanawongsa N, Crosson JC, Schillinger D, Karter AJ, Saha CK, Marrero DG. Getting under the skin of clinical inertia in insulin initiation: the Translating Research Into Action for Diabetes (TRIAD) Insulin Starts Project. Diabetes Educ. 2012;38(1):94–100.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Ogedegbe G, Mancuso CA, Allegrante JP. Expectations of blood pressure management in hypertensive African-American patients: a qualitative study. J Natl Med Assoc. 2004;96(4):442–449.PubMedPubMedCentral Ogedegbe G, Mancuso CA, Allegrante JP. Expectations of blood pressure management in hypertensive African-American patients: a qualitative study. J Natl Med Assoc. 2004;96(4):442–449.PubMedPubMedCentral
20.
Zurück zum Zitat Mann DM, Ponieman D, Leventhal H, Halm EA. Misconceptions about diabetes and its management among low-income minorities with diabetes. Diabetes Care. 2009;32(4):591–593.CrossRefPubMedPubMedCentral Mann DM, Ponieman D, Leventhal H, Halm EA. Misconceptions about diabetes and its management among low-income minorities with diabetes. Diabetes Care. 2009;32(4):591–593.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kravitz RL. Measuring patients’ expectations and requests. Ann Intern Med. 2001;134(9 Pt 2):881–888.CrossRefPubMed Kravitz RL. Measuring patients’ expectations and requests. Ann Intern Med. 2001;134(9 Pt 2):881–888.CrossRefPubMed
22.
Zurück zum Zitat Laiteerapong N, Fairchild PC, Nathan AG, Quinn MT, Huang ES. How information about the time requirements and legacy effects of treatments influence decision making in patients with diabetes and hypertension. BMJ Open Diabetes Res Care. Accepted 2016. Laiteerapong N, Fairchild PC, Nathan AG, Quinn MT, Huang ES. How information about the time requirements and legacy effects of treatments influence decision making in patients with diabetes and hypertension. BMJ Open Diabetes Res Care. Accepted 2016.
23.
Zurück zum Zitat Roccaforte WH, Burke WJ, Bayer BL, Wengel SP. Validation of a telephone version of the mini-mental state examination. J Am Geriatr Soc. 1992;40(7):697–702.CrossRefPubMed Roccaforte WH, Burke WJ, Bayer BL, Wengel SP. Validation of a telephone version of the mini-mental state examination. J Am Geriatr Soc. 1992;40(7):697–702.CrossRefPubMed
24.
Zurück zum Zitat Patton M. Designing Qualitative Studies: Purposeful Sampling. Qualitative evaluation and research methods. Beverly Hills, CA: Sage; 1990:169–186. Patton M. Designing Qualitative Studies: Purposeful Sampling. Qualitative evaluation and research methods. Beverly Hills, CA: Sage; 1990:169–186.
25.
Zurück zum Zitat Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - A metadata-drive methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.CrossRefPubMed Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - A metadata-drive methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.CrossRefPubMed
26.
Zurück zum Zitat Silverman, D. Doing Qualitative Research: A Practical Handbook, 2nd ed. London, UK: Sage Publications, LTD; 1999:456. Silverman, D. Doing Qualitative Research: A Practical Handbook, 2nd ed. London, UK: Sage Publications, LTD; 1999:456.
27.
Zurück zum Zitat Karter AJ, Subramanian U, Saha C, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010;33(4):733–735.CrossRefPubMedPubMedCentral Karter AJ, Subramanian U, Saha C, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010;33(4):733–735.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Grant RW, Pabon-Nau L, Ross KM, Youatt EJ, Pandiscio JC, Park ER. Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines. Diabetes Educ. 2011;37(1):78–84.CrossRefPubMed Grant RW, Pabon-Nau L, Ross KM, Youatt EJ, Pandiscio JC, Park ER. Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines. Diabetes Educ. 2011;37(1):78–84.CrossRefPubMed
29.
Zurück zum Zitat Ross SA. Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes. Am J Med. 2013;126(9 Suppl 1):S38–48.CrossRefPubMed Ross SA. Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes. Am J Med. 2013;126(9 Suppl 1):S38–48.CrossRefPubMed
30.
Zurück zum Zitat Moser M. Physician or clinical inertia: what is it? Is it really a problem? And what can be done about it? J Clin Hypertens (Greenwich). 2009;11(1):1–4.CrossRef Moser M. Physician or clinical inertia: what is it? Is it really a problem? And what can be done about it? J Clin Hypertens (Greenwich). 2009;11(1):1–4.CrossRef
Metadaten
Titel
Patients’ Future Expectations for Diabetes and Hypertension Treatments: “Through the Diet… I Think This is Going to Go Away.”
verfasst von
Paige C. Fairchild, MPH
Aviva G. Nathan, MPH
Michael Quinn, PhD
Elbert S. Huang, MD, MPH
Neda Laiteerapong, MD, MS
Publikationsdatum
11.10.2016
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 1/2017
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3871-3

Weitere Artikel der Ausgabe 1/2017

Journal of General Internal Medicine 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.